Podcast
MSL Talk: Tom Caravela, Hahn-Ey Lee
Lead with Strengths… Develop Your Weaknesses
Summary
In this episode, Tom Caravela explores the importance of recognizing and utilizing personal strengths in both professional and personal realms. He shares research on the benefits of focusing on strengths over weaknesses and offers guidance on identifying and leveraging these in resumes and interviews. Tom also provides strategies for career growth and job satisfaction, including managerial tips for nurturing employee strengths. The concept of altercasting is introduced, encouraging listeners to apply their strengths daily while acknowledging areas for growth. The episode wraps up with a recap and a call to action for listener engagement and sharing.
Tom Caravela, Managing Partner at The Carolan Group, discusses why it is important to Lead with Strengths and Develop Your Weaknesses
Tom shares…
👉 Positive psychology research about success from using your strengths
👉 Why it is important to identify your strengths
👉 Examples of how strengths should be used throughout your career
👉 How to use your strengths in your personal life
👉 How and why it is important to develop your weaknesses
personal strengths, career growth, job satisfaction, positive psychology, altercasting
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Hahn-Ey Lee
Podcast
MSL Talk: Tom Caravela, Ruchit Parikh
Market Access and the MSL Role
Article
Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
Article
Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
Article
Vanessa Arciero, BS, Seanthel Delos Santos, Liza Koshy
Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review
Article
iNIZIO